Partnership to address increasing demand for protein biomarker testing in pharmaceutical research and development in the Chinese market

BEIJING, China. – Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd., to provide Aushon’s comprehensive suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.

LightArray operates a comprehensive drug development services laboratory in Wuxi, China and will now provide researchers with a local, centralized protein biomarker testing laboratory employing Aushon’s protein biomarker technologies including:

•A growing menu of 300+ validated assays

•Multiplex biomarker sample testing service

•Multiplex protein biomarker kits

•Custom arrays and assay development•Array imaging and analysis systems

“Our strategic partnership with LightArray enables companies located in China and involved in pre-clinical and clinical research to take advantage of our full range of biomarker products and services, including our flexible sample testing service and growing menu of more than 300 biomarkers in key therapeutic areas such as oncology, inflammation, cardiovascular disease, and diabetes,” said Pete Honkanen, CEO of Aushon. “They can also count on the same exacting level of reliability, performance and support that we deliver to our current customers in the United States, Europe and Southeast Asia.”

“We are extremely excited by the opportunity to assist Aushon in bringing their portfolio of multiplex biomarker services and products into the emerging China market,” said Alan Zhang, President and CEO of LightArray. “The adoption of biomarkers as a critical research tool in pre-clinical and clinical studies is growing rapidly in China, and our ability to provide local, regional access to the proven Aushon multiplex technology platform will be vital. We also look forward to providing the same unrivaled service and support to our customers that Aushon has built its reputation on.”

About LightArray Biotech

LightArray Biotech Co., Ltd. provides microarray technology products and fast, accurate and comprehensive multiplex biomarker solutions to companies and institutions involved in pre-clinical and clinical research in China. Headquartered in Shanghai, we also have a full service testing laboratory, located in Wuxi, China, that was established with support from the Wuxi government as part of their ongoing investment in leading-edge technology companies that are “based in the Yangtze River Delta to serve the whole of China.” A corporate commitment to providing the highest quality products, service and support, combined with a passionate dedication to offering advanced multiplex biomarker solutions means our customers can rely on us to help move their research forward and improve their results. For more information, please visit www.lightarray.com or contact us at info@lightarray.com.

About Aushon BioSystems

Aushon BioSystems provides a comprehensive suite of microarray instruments, consumables and services to leading pharmaceutical, biotechnology, academic and diagnostic clients worldwide. Our unique combination of advanced microarray printing technology, robust biomarker content and innovative multiplex immunoassay development and detection systems delivers exceptional performance, quality and reliability that accelerate pre-clinical and clinical biomarker research. Our customers trust us to provide the most reliable protein biomarker data available, which lowers costs and improves research productivity. For more information, please visit www.aushon.com